{"id":22774,"date":"2023-05-30T11:22:09","date_gmt":"2023-05-30T18:22:09","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=22774"},"modified":"2026-03-19T14:39:19","modified_gmt":"2026-03-19T21:39:19","slug":"kesimpta-an-fda-approved-solution-for-multiple-sclerosis","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/","title":{"rendered":"Kesimpta: Una soluci\u00f3n aprobada por la FDA para la esclerosis m\u00faltiple"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Kesimpta es un medicamento de prescripci\u00f3n aprobado por la FDA que se administra para tratar ciertos tipos de esclerosis m\u00faltiple (EM) en adultos. Contiene el principio activo ofatumumab. Kesimpta se presenta en soluci\u00f3n l\u00edquida que se inyecta subcut\u00e1neamente mediante plumas o jeringas monodosis.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Antes de tomar Kesimpta, es fundamental informar a su m\u00e9dico o farmac\u00e9utico:&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Sobre cualquier alergia, incluidas las alergias a medicamentos.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si est\u00e1 tomando alg\u00fan medicamento recetado, productos a base de hierbas, vitaminas, suplementos o medicamentos de venta libre.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Sobre su condici\u00f3n m\u00e9dica y antecedentes de enfermedades. Si ha tenido alg\u00fan trastorno o padece actualmente alguna enfermedad cr\u00f3nica o prolongada, aseg\u00farese de compartir esta informaci\u00f3n. Por ejemplo, informe a su m\u00e9dico sobre infecciones pasadas o actuales, problemas inmunitarios o enfermedades hep\u00e1ticas, como la hepatitis B.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si est\u00e1 amamantando, embarazada o planea quedar embarazada, Kesimpta no debe usarse durante el embarazo ya que puede da\u00f1ar al feto.<\/span><\/li>\n<\/ul>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#What_Is_Kesimpta\" >\u00bfQu\u00e9 es Kesimpta?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#What_Is_Kesimpta_Used_To_Treat\" >\u00bfPara qu\u00e9 se utiliza el Kesimpta?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#How_Does_Kesimpta_Work\" >\u00bfC\u00f3mo funciona Kesimpta?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#How_Is_Kesimpta_Administered\" >\u00bfC\u00f3mo se administra Kesimpta?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#Kesimpta_Side_Effects\" >Efectos secundarios del Kesimpta<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#Strength\" >Fortaleza<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#Dose\" >Dosis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#Storage_and_Handling_Guidelines\" >Pautas de almacenamiento y manipulaci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#Kesimpta_Drug_Interactions\" >Interacciones farmacol\u00f3gicas de Kesimpta<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#Cost\" >Costo<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#FAQs\" >Preguntas frecuentes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#Conclusion\" >Conclusi\u00f3n<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Kesimpta\"><\/span>\u00bfQu\u00e9 es Kesimpta?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kesimpta es un <a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/monoclonal-antibody\">anticuerpo monoclonal<\/a> que se utiliza para tratar la esclerosis m\u00faltiple (EM) recurrente, incluido el s\u00edndrome cl\u00ednicamente aislado (CIS), la enfermedad progresiva secundaria activa y la enfermedad remitente-recurrente.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Kesimpta_Used_To_Treat\"><\/span>\u00bfPara qu\u00e9 se utiliza el Kesimpta?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El Kesimpta pertenece a la clase de f\u00e1rmacos conocidos como anticuerpos monoclonales. Se utiliza para retardar el riesgo y la progresi\u00f3n de la esclerosis m\u00faltiple recurrente.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Kesimpta se utiliza para tratar las siguientes formas de esclerosis m\u00faltiple recurrente:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">S\u00edndrome cl\u00ednicamente aislado<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Enfermedad de progresi\u00f3n secundaria activa<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Esclerosis m\u00faltiple (EM) recurrente-remitente<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">La esclerosis m\u00faltiple es una enfermedad del sistema nervioso central que causa inflamaci\u00f3n y da\u00f1o a los nervios, la m\u00e9dula espinal y el cerebro. Provoca que el sistema inmunitario destruya... <a href=\"https:\/\/medlineplus.gov\/ency\/article\/002261.htm\">mielina<\/a>, una capa que cubre los nervios.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_Kesimpta_Work\"><\/span>\u00bfC\u00f3mo funciona Kesimpta?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El Kesimpta no cura la esclerosis m\u00faltiple; sin embargo, se utiliza para ralentizar la progresi\u00f3n de la enfermedad y reducir la tasa de reca\u00eddas. El medicamento act\u00faa dirigi\u00e9ndose a los ant\u00edgenos de las c\u00e9lulas B y uni\u00e9ndose a ellos, reduciendo as\u00ed su n\u00famero. Esto ralentiza el ataque del sistema inmunitario a los nervios y disminuye la inflamaci\u00f3n.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Kesimpta_Administered\"><\/span>\u00bfC\u00f3mo se administra Kesimpta?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Este medicamento debe usarse exactamente como lo recomiende su m\u00e9dico.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Kesimpta se administra mediante inyecci\u00f3n debajo de la piel (v\u00eda subcut\u00e1nea) en una parte grasa del cuerpo, como el abdomen o los muslos.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Generalmente se inyecta mediante plumas o jeringas precargadas.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">El Kesimpta es administrado por un profesional m\u00e9dico, generalmente en un centro m\u00e9dico. El paciente puede autoadministrarse el medicamento, pero es necesario aprender y practicar con un profesional de la salud c\u00f3mo inyectarlo por v\u00eda subcut\u00e1nea.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">No inyecte Kesimpta en piel da\u00f1ada, como piel enrojecida, hinchada, sensible, amoratada, dura o escamosa.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si olvida una dosis de Kesimpta, hable con su proveedor de atenci\u00f3n m\u00e9dica tan pronto como recuerde administrar el medicamento sin esperar a la siguiente dosis.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">El Kesimpta est\u00e1 aprobado solo para adultos. Se desconoce si el medicamento es seguro y eficaz para su uso en ni\u00f1os con esclerosis m\u00faltiple.<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kesimpta_Side_Effects\"><\/span>Efectos secundarios del Kesimpta<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/kesimpta-side-effects.jpg\" alt=\"Elderly patient with Kesimpta side effects\" class=\"wp-image-22776\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/kesimpta-side-effects.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/kesimpta-side-effects-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/kesimpta-side-effects-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/kesimpta-side-effects-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/kesimpta-side-effects-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/kesimpta-side-effects-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/kesimpta-side-effects-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">Los efectos secundarios leves incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Dolor de cabeza<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor muscular<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fatiga<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fiebre y escalofr\u00edos<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Infecci\u00f3n del tracto respiratorio superior&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Infecci\u00f3n del tracto urinario&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Los efectos secundarios graves incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Enrojecimiento, hinchaz\u00f3n, sangrado, picaz\u00f3n o dolor en el lugar de la inyecci\u00f3n.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dificultad para respirar<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Mareos repentinos<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Latidos card\u00edacos irregulares o r\u00e1pidos<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">P\u00e9rdida de coordinaci\u00f3n<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor de cabeza severo<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Aleteo en el pecho&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Temblores<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">sudoraci\u00f3n profusa<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fiebre alta&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Visi\u00f3n borrosa&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Los efectos secundarios leves del Kesimpta desaparecen por s\u00ed solos a medida que el cuerpo se acostumbra al medicamento. Sin embargo, si experimenta efectos secundarios graves o si los efectos secundarios leves se vuelven intolerables, persistentes o graves, consulte a su m\u00e9dico o farmac\u00e9utico de inmediato.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Strength\"><\/span>Fortaleza<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kesimpta est\u00e1 disponible en la siguiente concentraci\u00f3n: 20 mg\/0,4 ml (20 mg por 0,4 ml).<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dose\"><\/span>Dosis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Las dosis de Kesimpta pueden variar seg\u00fan las condiciones del paciente y pueden depender de algunos factores, como:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">El tipo y la gravedad de la esclerosis m\u00faltiple<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Otras condiciones de salud del paciente<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Vacunas del paciente<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Las dosis habituales recomendadas se detallan a continuaci\u00f3n:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">La dosis inicial de Kesimpta es de 20 mg administrada mediante inyecci\u00f3n subcut\u00e1nea en las semanas 0, 1 y 2.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Se administra una dosis posterior de 20 mg mediante inyecci\u00f3n subcut\u00e1nea una vez al mes a partir de la semana 4.<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Storage_and_Handling_Guidelines\"><\/span>Pautas de almacenamiento y manipulaci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Se deben seguir las siguientes pautas de almacenamiento y manipulaci\u00f3n durante el uso de Kesimpta:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">El medicamento debe conservarse en el refrigerador entre 2\u00b0C y 8\u00b0C.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">No agite ni congele Kesimpta.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Proteja el medicamento de la luz guard\u00e1ndolo en su embalaje original hasta su uso.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Mantenga Kesimpta fuera del alcance de los ni\u00f1os.<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kesimpta_Drug_Interactions\"><\/span>Interacciones farmacol\u00f3gicas de Kesimpta<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kesimpta tiene varias interacciones medicamentosas; por lo tanto, es fundamental informar a su m\u00e9dico y farmac\u00e9utico sobre todos los medicamentos y suplementos que utiliza antes de comenzar a tomar Kesimpta.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Kesimpta puede interactuar con medicamentos que debilitan el sistema inmunol\u00f3gico, como:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\"><a href=\"https:\/\/my.clevelandclinic.org\/health\/drugs\/10418-immunosuppressants\">Inmunosupresores<\/a> (medicamentos que se utilizan para prevenir el rechazo de trasplantes de \u00f3rganos)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Esteroides<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Medicamentos contra el c\u00e1ncer<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ciertas vitaminas, productos a base de hierbas, suplementos, medicamentos de venta libre y medicamentos con receta.<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span>Costo<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El costo de Kesimpta depende de varios factores, entre ellos:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">La ubicaci\u00f3n y el tipo de farmacia que visita<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Su estado de salud y su historial de enfermedades<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">El n\u00famero de dosis prescritas por su m\u00e9dico<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si su seguro cubre o no el costo del tratamiento farmacol\u00f3gico Kesimpta<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">El costo promedio de una inyecci\u00f3n subcut\u00e1nea de 20 mg\/0.4 ml es de aproximadamente $8,606 para un suministro de 0.4 ml. Cont\u00e1ctenos si est\u00e1 interesado. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">asistencia financiera o de copago<\/a>.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span>Preguntas frecuentes<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h4 class=\"wp-block-heading\">\u00bfCu\u00e1nto dura el tratamiento?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Kesimpta es un tratamiento farmacol\u00f3gico a largo plazo. Inicialmente, se administra una vez a la semana durante tres semanas, y luego se aumenta a una vez al mes hasta la progresi\u00f3n de la enfermedad o seg\u00fan lo recomiende el m\u00e9dico.<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">\u00bfEs Kesimpta un f\u00e1rmaco de quimioterapia?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">S\u00ed. En 2009, la FDA aprob\u00f3 por primera vez el Kesimpta como inyecci\u00f3n intravenosa para el tratamiento de la leucemia linfoc\u00edtica cr\u00f3nica. Posteriormente, la FDA estadounidense tambi\u00e9n aprob\u00f3 la inyecci\u00f3n subcut\u00e1nea de Kesimpta para el tratamiento de las formas recurrentes de esclerosis m\u00faltiple en adultos.<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">\u00bfEs Kesimpta un medicamento seguro?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">La FDA ha aprobado el Kesimpta como un medicamento seguro para el tratamiento de la esclerosis m\u00faltiple en adultos. Puede ser seguro si se usa exactamente como lo recomienda su m\u00e9dico. El medicamento puede debilitar el sistema inmunitario y aumentar el riesgo de infecciones leves o efectos secundarios. Se recomienda consultar a su m\u00e9dico si experimenta cualquier efecto secundario grave o intolerable relacionado con la inyecci\u00f3n.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusi\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El Kesimpta es un medicamento de prescripci\u00f3n aprobado por la FDA que se utiliza para tratar un trastorno del sistema nervioso central en adultos, conocido como esclerosis m\u00faltiple. Se administra una vez al mes mediante inyecci\u00f3n subcut\u00e1nea durante algunos meses o m\u00e1s, seg\u00fan la evoluci\u00f3n de la salud del paciente. El Kesimpta act\u00faa disminuyendo <a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/b-cell\">c\u00e9lulas B<\/a>, retardando el ataque del sistema inmunol\u00f3gico a los nervios y reduciendo la inflamaci\u00f3n.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Kesimpta es un medicamento de prescripci\u00f3n aprobado por la FDA que se administra para tratar ciertos tipos de esclerosis m\u00faltiple (EM) en adultos. Contiene el principio activo ofatumumab. Kesimpta se presenta en soluci\u00f3n l\u00edquida que se inyecta subcut\u00e1neamente mediante plumas o jeringas monodosis.\u00a0<\/p>","protected":false},"author":13,"featured_media":22778,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[64],"tags":[17],"class_list":["post-22774","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-discontinued","tag-dr-saba-rassouli"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kesimpta: An FDA-Approved Solution for Multiple Sclerosis<\/title>\n<meta name=\"description\" content=\"Learn about Kesimpta (ofatumumab) and how it treats mutiple sclerosis. Topics include how the drug works, side effects, dosage and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kesimpta: An FDA-Approved Solution for Multiple Sclerosis\" \/>\n<meta property=\"og:description\" content=\"Learn about Kesimpta (ofatumumab) and how it treats mutiple sclerosis. Topics include how the drug works, side effects, dosage and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-30T18:22:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T21:39:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/\"},\"author\":{\"name\":\"Dr. Saba Rassouli, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\"},\"headline\":\"Kesimpta: An FDA-Approved Solution for Multiple Sclerosis\",\"datePublished\":\"2023-05-30T18:22:09+00:00\",\"dateModified\":\"2026-03-19T21:39:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/\"},\"wordCount\":1072,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/multiple-sclerosis2.jpg\",\"keywords\":[\"Dr. Saba Rassouli\"],\"articleSection\":[\"Discontinued\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/\",\"name\":\"Kesimpta: An FDA-Approved Solution for Multiple Sclerosis\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/multiple-sclerosis2.jpg\",\"datePublished\":\"2023-05-30T18:22:09+00:00\",\"dateModified\":\"2026-03-19T21:39:19+00:00\",\"description\":\"Learn about Kesimpta (ofatumumab) and how it treats mutiple sclerosis. Topics include how the drug works, side effects, dosage and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/multiple-sclerosis2.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/multiple-sclerosis2.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Orange ribbon, stethoscope and paper brain cutout for multiple sclerosis awareness\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/discontinued\\\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kesimpta: An FDA-Approved Solution for Multiple Sclerosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\",\"name\":\"Dr. Saba Rassouli, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"caption\":\"Dr. Saba Rassouli, PharmD\"},\"description\":\"Dr. Saba Rassouli, PharmD was born and raised in Iran. She received her pharmacy degree from Marshall B. Ketchum University in 2022, where she graduated cum laude. The most rewarding part of her job is having the opportunity to care for each patient as if they were family and hearing about how happy and satisfied they are with the services provided by AmeriPharma. In her free time, she likes to go on walks, read books, and try different restaurants and foods.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/saba-rassouli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kesimpta: Una soluci\u00f3n aprobada por la FDA para la esclerosis m\u00faltiple","description":"Aprenda sobre Kesimpta (ofatumumab) y c\u00f3mo trata la esclerosis m\u00faltiple. Los temas incluyen c\u00f3mo funciona el medicamento, sus efectos secundarios, dosis y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/","og_locale":"es_MX","og_type":"article","og_title":"Kesimpta: An FDA-Approved Solution for Multiple Sclerosis","og_description":"Learn about Kesimpta (ofatumumab) and how it treats mutiple sclerosis. Topics include how the drug works, side effects, dosage and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-05-30T18:22:09+00:00","article_modified_time":"2026-03-19T21:39:19+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg","type":"image\/jpeg"}],"author":"Dr. Saba Rassouli, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Saba Rassouli, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/"},"author":{"name":"Dr. Saba Rassouli, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01"},"headline":"Kesimpta: An FDA-Approved Solution for Multiple Sclerosis","datePublished":"2023-05-30T18:22:09+00:00","dateModified":"2026-03-19T21:39:19+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/"},"wordCount":1072,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg","keywords":["Dr. Saba Rassouli"],"articleSection":["Discontinued"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/","url":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/","name":"Kesimpta: Una soluci\u00f3n aprobada por la FDA para la esclerosis m\u00faltiple","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg","datePublished":"2023-05-30T18:22:09+00:00","dateModified":"2026-03-19T21:39:19+00:00","description":"Aprenda sobre Kesimpta (ofatumumab) y c\u00f3mo trata la esclerosis m\u00faltiple. Los temas incluyen c\u00f3mo funciona el medicamento, sus efectos secundarios, dosis y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg","width":1280,"height":853,"caption":"Orange ribbon, stethoscope and paper brain cutout for multiple sclerosis awareness"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/vi\/discontinued\/kesimpta-an-fda-approved-solution-for-multiple-sclerosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Kesimpta: An FDA-Approved Solution for Multiple Sclerosis"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01","name":"Dra. Saba Rassouli, Farmac\u00e9utica","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","caption":"Dr. Saba Rassouli, PharmD"},"description":"La Dra. Saba Rassouli, doctora en farmacia, naci\u00f3 y creci\u00f3 en Ir\u00e1n. Obtuvo su t\u00edtulo en farmacia en la Universidad Marshall B. Ketchum en 2022, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es tener la oportunidad de atender a cada paciente como si fuera de su familia y escuchar lo contentos y satisfechos que est\u00e1n con los servicios de AmeriPharma. En su tiempo libre, le gusta pasear, leer y probar diferentes restaurantes y comidas.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"uagb_comment_info":0,"uagb_excerpt":"Kesimpta is an FDA-approved prescription medication that is given to treat certain types of multiple sclerosis (MS) in adults. It contains the active ingredient, ofatumumab. Kesimpta comes as a liquid solution that is injected under the skin subcutaneously, using pens or single-dose syringes.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/05\/multiple-sclerosis2.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/discontinued\/\" rel=\"category tag\">Discontinued<\/a>","rttpg_excerpt":"Kesimpta is an FDA-approved prescription medication that is given to treat certain types of multiple sclerosis (MS) in adults. It contains the active ingredient, ofatumumab. Kesimpta comes as a liquid solution that is injected under the skin subcutaneously, using pens or single-dose syringes.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=22774"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22774\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/22778"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=22774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=22774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=22774"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}